Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
US Army
Express Scripts
Cantor Fitzgerald
Teva
Boehringer Ingelheim
Fuji
Moodys

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020161

« Back to Dashboard

NDA 020161 describes POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in two NDAs. It is available from two suppliers. Additional details are available on the POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER profile page.

The generic ingredient in POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER is potassium chloride. There are two hundred and thirty-five drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 020161
Tradename:POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER
Applicant:Icu Medical Inc
Ingredient:potassium chloride
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020161
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161 NDA Hospira, Inc. 0409-7074 N 0409-7074-26
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161 NDA Hospira, Inc. 0409-7075 N 0409-7075-14

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength745MG/100ML
Approval Date:Nov 30, 1992TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1.49GM/100ML
Approval Date:Nov 30, 1992TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.24GM/100ML
Approval Date:Aug 11, 1998TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Julphar
Express Scripts
AstraZeneca
Cerilliant
Mallinckrodt
McKesson
Deloitte
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.